Testing effectiveness (Phase 2)Ended earlyNCT03970200
What this trial is testing
Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)
Who this might be right for
Severe Clostridium Difficile InfectionSevere-Complicated/Fulminant Clostridium Difficile Infection
University of Pennsylvania 15